LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹28,646 Cr | ₹23,695 Cr | ₹22,800 Cr | ₹21,651 Cr | ₹23,430 Cr |
What is the latest Total Liabilities ratio of LUPIN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹28,646 Cr |
| Mar2024 | ₹23,695 Cr |
| Mar2023 | ₹22,800 Cr |
| Mar2022 | ₹21,651 Cr |
| Mar2021 | ₹23,430 Cr |
How is Total Liabilities of LUPIN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹28,646 Cr | 20.90 | |
| Mar2024 | ₹23,695 Cr | 3.92 | |
| Mar2023 | ₹22,800 Cr | 5.31 | |
| Mar2022 | ₹21,651 Cr | -7.59 | |
| Mar2021 | ₹23,430 Cr | - | |
Compare Total Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹107,708.0 Cr | 0.5% | 6.9% | 16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 0.5% |
6.9% |
16.2% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses